Adam Cheknis

1.4k total citations
19 papers, 1.1k citations indexed

About

Adam Cheknis is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Adam Cheknis has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 14 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Adam Cheknis's work include Clostridium difficile and Clostridium perfringens research (19 papers), Microscopic Colitis (14 papers) and Viral gastroenteritis research and epidemiology (10 papers). Adam Cheknis is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (19 papers), Microscopic Colitis (14 papers) and Viral gastroenteritis research and epidemiology (10 papers). Adam Cheknis collaborates with scholars based in United States, United Kingdom and Australia. Adam Cheknis's co-authors include Dale N. Gerding, Stuart Johnson, Susan P. Sambol, Ciarán P. Kelly, Kianoosh Katchar, Xinhua Chen, Jeffrey D. Goldsmith, N. Nanda Nanthakumar, Kristin Nagaro and P.S. Sears and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Adam Cheknis

19 papers receiving 1.0k citations

Peers

Adam Cheknis
Anne J Gonzales-Luna United States
Michelle M. Merrigan United States
Farah Babakhani United States
C. H. Chilton United Kingdom
Danyel Olson United States
Anilrudh A. Venugopal United States
S. L. Todhunter United Kingdom
Jon J. Vernon United Kingdom
A. R. Welch United Kingdom
Anne J Gonzales-Luna United States
Adam Cheknis
Citations per year, relative to Adam Cheknis Adam Cheknis (= 1×) peers Anne J Gonzales-Luna

Countries citing papers authored by Adam Cheknis

Since Specialization
Citations

This map shows the geographic impact of Adam Cheknis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Cheknis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Cheknis more than expected).

Fields of papers citing papers by Adam Cheknis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Cheknis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Cheknis. The network helps show where Adam Cheknis may publish in the future.

Co-authorship network of co-authors of Adam Cheknis

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Cheknis. A scholar is included among the top collaborators of Adam Cheknis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Cheknis. Adam Cheknis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Skinner, Andrew M, Adam Cheknis, Vanessa Stevens, et al.. (2024). Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures. Antimicrobial Agents and Chemotherapy. 68(8). e0069824–e0069824. 2 indexed citations
2.
Skinner, Andrew M, et al.. (2023). Antimicrobial susceptibility of Clostridioides difficile to omadacycline and comparator antimicrobials. Journal of Antimicrobial Chemotherapy. 78(7). 1779–1784. 4 indexed citations
3.
Wright, Lorinda M., et al.. (2023). Characteristics and outcomes of Clostridioides difficile infection after a change in the diagnostic testing algorithm. Infection Control and Hospital Epidemiology. 45(1). 57–62. 1 indexed citations
4.
Wright, Lorinda M., Andrew M Skinner, Adam Cheknis, et al.. (2023). Effect of the COVID-19 Pandemic on Rates and Epidemiology of Clostridioides difficile Infection in One VA Hospital. Antibiotics. 12(7). 1159–1159. 4 indexed citations
5.
Sambol, Susan P., Stuart Johnson, Adam Cheknis, & Dale N. Gerding. (2022). Absence of toxin gene transfer from Clostridioides difficile strain 630Δerm to nontoxigenic C. difficile strain NTCD-M3r in filter mating experiments. PLoS ONE. 17(6). e0270119–e0270119. 3 indexed citations
6.
‍Kim, Do Young, Adam Cheknis, Michael Y. Lin, et al.. (2022). 403. Strain Epidemiology of Clostridioides difficile across Three Geographically Distinct Medical Centers in Chicago. Open Forum Infectious Diseases. 9(Supplement_2). 2 indexed citations
8.
Cheknis, Adam, Laurent Chesnel, Suzanne E. Dale, et al.. (2020). Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities. Journal of Antimicrobial Chemotherapy. 75(11). 3120–3125. 5 indexed citations
9.
Cheknis, Adam, Stuart Johnson, Laurent Chesnel, et al.. (2018). Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015. Anaerobe. 53. 38–42. 27 indexed citations
10.
Knight, Katherine L., et al.. (2016). Induction of antitoxin responses in Clostridium-difficile-infected patients compared to healthy blood donors. Anaerobe. 41. 91–103. 10 indexed citations
11.
Lopansri, Bert K., Adam Cheknis, James R. Osmolski, et al.. (2015). Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027. Antimicrobial Agents and Chemotherapy. 60(1). 418–423. 44 indexed citations
12.
Carter, Glen P., Anjana Chakravorty, Steven J. Mileto, et al.. (2015). Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections. mBio. 6(3). e00551–e00551. 222 indexed citations
13.
Nagaro, Kristin, et al.. (2013). Nontoxigenic Clostridium difficile Protects Hamsters against Challenge with Historic and Epidemic Strains of Toxigenic BI/NAP1/027 C. difficile. Antimicrobial Agents and Chemotherapy. 57(11). 5266–5270. 61 indexed citations
14.
Sambol, Susan P., Adam Cheknis, Kristin Nagaro, et al.. (2012). Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain. Clinical Infectious Diseases. 55(3). 351–357. 151 indexed citations
15.
Siddiqui, Farida, Jennifer R. O’Connor, Kristin Nagaro, et al.. (2011). Vaccination With Parenteral Toxoid B Protects Hamsters Against Lethal Challenge With Toxin A–Negative, Toxin B–Positive Clostridium difficile but Does Not Prevent Colonization. The Journal of Infectious Diseases. 205(1). 128–133. 31 indexed citations
16.
Cheknis, Adam, Susan P. Sambol, David M. Davidson, et al.. (2009). Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005–2007. Anaerobe. 15(6). 230–233. 48 indexed citations
17.
Chen, Xinhua, Kianoosh Katchar, Jeffrey D. Goldsmith, et al.. (2008). A Mouse Model of Clostridium difficile–Associated Disease. Gastroenterology. 135(6). 1984–1992. 399 indexed citations
18.
Chen, Xinhua, Kianoosh Katchar, Jeffrey D. Goldsmith, et al.. (2008). BASIC—ALIMENTARY TRACT A Mouse Model of Clostridium difficile-Associated Disease. 1 indexed citations
19.
Sambol, Susan P., et al.. (2007). Infection of Hamsters with Historical and Epidemic BI Types ofClostridium difficile. The Journal of Infectious Diseases. 196(12). 1813–1819. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026